Consolidated Condensed Statements of Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Net loss including noncontrolling interests	$ (601,728)	$ (893,312)
Unrealized gain (loss) on short-term investments
Foreign currency translation adjustment	(108,100)	40,750
Comprehensive loss including noncontrolling interests	(709,828)	(852,562)
Comprehensive loss attributable to noncontrolling interests	46,819	6,378
Comprehensive loss attributable to Cleveland BioLabs, Inc.	$ (663,009)	$ (846,184)